9. Research and development expenses
18 of 54
- Home
- Bayer Group
- Key Data
- Management Report
Overview of Sales, Earnings and Financial Position- Business and Operating Environment
- Performance by Subgroup, Segment and Region
- Earnings; Asset and Financial Position of the Bayer Group
- Earnings; Asset and Financial Position of Bayer AG
- Takeover-Relevant Information
- Corporate Governance Report
- Research and Development
- Sustainability
- Events After the Reporting Period
- Future Perspectives
- Financial Statements
- Bayer Stock
- Bayer Magazine
- Services
- Income Statements
- Comprehensive Income
- Financial Position
- Statements of Cash Flows
- Changes in Equity
Notes to the Consolidated Financial Statements of the Bayer Group- Key data by segment and region
- General information
- Effects of new accounting pronouncements
- Basic principles, methods and critical accounting policies
- Segment reporting
- Scope of consolidation; subsidiaries and affiliates
- Notes to the Income Statements
- Notes to the Statements of Financial Position
- Notes to the Statements of Cash Flows
- Other Information
- Management’s Statement of Responsibility for Financial Reporting
- Responsibility Statement
- Auditor’s Report
Bayer Links- Bayer Global
- Bayer HealthCare
- Bayer CropScience
- Bayer MaterialScience
- Bayer Business Services
- Bayer Technology Services
- Currenta
- Special Interest
Investor Relations- Press
- Jobs and Career
- Foundations
- Sports
- Culture
Search
Advanced Search
Links
Services
Full Year 2009 Results
Info
